Check Cap Ltd (MBAI)
Check Cap Ltd. is a clinical-stage medical diagnostics company focused on capsule-based screening technologies. The company was incorporated in 2004 and is based in Isfiya, Israel. Its common stock is listed on NASDAQ under the ticker MBAI. As an early-stage healthcare company, Check Cap’s business is centered on developing diagnostic products for screening applications.
Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.
| Ticker | Fair Value | Fair Value Upside/Downside | Fair Value Rating | Analyst Price Target | Analyst Target Upside/Downside | Analyst Target Rating | Overall Financial Health | Upcoming Dividend Ex-Date | Dividend Payment Date | Upcoming Dividend | Dividend Yield | Next Earnings Date | P/E Ratio | Price-to-Book Ratio | Price-to-Sales Ratio | Market Cap | Enterprise Value | Total Debt / Total Capital | Free Float / Shares Outstanding | Altman Z-Score | Payout Ratio | Free Cash Flow / Net Income |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
NASDAQ-MBAI
|
$0.74
|
-28.2% Downside
|
Overvalued
|
—
|
—
|
—
|
Fair
|
—
|
—
|
—
|
0.0%
|
August 3, 2026
|
1.8x
|
2.1x
|
—
|
6.924 M
|
560.359 K
|
0.2%
|
79.9%
|
-81.9
|
—
|
-1.1%
|